TGTX

NASDAQStock

TG Therapeutics, Inc.

$26.96-1.09 (-3.89%)

52-Week Range

$26.39
$45.51

Key Stats

Market Cap

4.3B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86

Volume

1.2M

Avg Volume

1.9M

Performance

1M

-6.52%

3M

-14.23%

6M

-15.15%

YTD

-7.99%

1Y

-27.31%

3Y

+81.05%

5Y

-43.99%

Price Chart

ETF Exposure

TGTX is held by 118 ETFs

ETFFund NameWeight
AOKiShares Core 30/70 Conservative Allocation ETF0.00%
AOMiShares Core 40/60 Moderate Allocation ETF0.00%
AORiShares Core 60/40 Balanced Allocation ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
VLUState Street SPDR S&P 1500 Value Tilt ETF0.00%
DCORDimensional - US Core Equity 1 ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 3 of 3

About TGTX ETF Exposure

TG Therapeutics, Inc. (TGTX) is held by 118 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 4.3B, TGTX is a widely held institutional stock. The stock currently trades at $26.96. Investors can gain exposure to TGTX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold TGTX, sorted by portfolio weight.